Diclofenac Sodium’s contribution to IVF outcomes in PPOS and GnRH antagonist cycles

Oocyte retrieval timing is critical for oocyte competence, yet prolonging the standard interval risks premature ovulation. Nonsteroidal anti-inflammatory drugs (NSAIDs) selectively inhibit COX-2–driven prostaglandin synthesis and can reversibly delay or even prevent follicular rupture, yet their efficacy and safety in controlled ovarian stimulation protocols remain inadequately characterized. A total of 4,480 conventional IVF/ICSI cycles (2,852 PPOS and 1,628 GnRH antagonist) were included. A nearest-neighbor random matching approach was employed to pair the DS-exposed group and the control group with a 1:2 ratio in PPOS ( n = 158 in the DS group and n = 316 in the control group) and GnRH antagonist ( n = 298 in the DS group and n = 596 in the control group) protocols. Five variables were included in the propensity score estimation: age, antral follicle count, basal luteinizing hormone (LH), serum LH, and number of follicles > 10 mm on trigger day. After matching, the DS group demonstrated a significantly prolonged hCG-to-oocyte retrieval interval in both PPOS and GnRH antagonist cohorts. No significant differences were observed in baseline characteristics and hormone levels (all p > 0.05). DS exposure significantly improved oocyte retrieval rate (88.95 ± 17.36 vs. 77.99 ± 22.60, p < 0.001 in PPOS; 89.35 ± 16.70% vs. 78.99 ± 21.21% in GnRH antagonist, p < 0.001) and good-quality embryo rate (62.74 ± 29.06% vs. 49.67 ± 31.54% in PPOS, p < 0.001; 70.6 ± 27.0% vs. 48.0 ± 32.5% in GnRH antagonist, p < 0.001). In the GnRH antagonist cohort, the implantation rate was significantly higher (28.63% vs. 21.38%, p = 0.015) in the DS group in fresh embryo transfer cycles. No significant differences in clinical pregnancy rate and miscarriage rate were observed between the DS-exposed and control groups (all p > 0.05). A single 75-mg diclofenac sodium (DS) tablet administered 20 h after human chorionic gonadotropin (hCG) trigger prolonged the trigger-to-retrieval interval to 39–43 h, significantly increasing good-quality embryo rate and retrieval efficiency without compromising pregnancy outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Ovarian Research
Published
2026-11-20
DOI
https://doi.org/10.1186/s13048-026-02335-z
Primary Topic
Reproductive Biology and Fertility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diclofenac Sodium’s contribution to IVF outcomes in PPOS and GnRH antagonist cycles

Jianting Lao, Qianwen Xi, Renfei Cai, 赵磊文 et al.
2 links
Journal of Ovarian Research
Reproductive Biology and Fertility
article

Diclofenac Sodium’s contribution to IVF outcomes in PPOS and GnRH antagonist cycles

Jianting Lao, Qianwen Xi, Renfei Cai, 赵磊文, Xi Shen, Ling Wu, Dongying Li, Yanping Kuang, Hong Yang, Yao Wang, Linxi Zhang, Meiping Sheng
article en

Abstract

Oocyte retrieval timing is critical for oocyte competence, yet prolonging the standard interval risks premature ovulation. Nonsteroidal anti-inflammatory drugs (NSAIDs) selectively inhibit COX-2–driven prostaglandin synthesis and can reversibly delay or even prevent follicular rupture, yet their efficacy and safety in controlled ovarian stimulation protocols remain inadequately characterized. A total of 4,480 conventional IVF/ICSI cycles (2,852 PPOS and 1,628 GnRH antagonist) were included. A nearest-neighbor random matching approach was employed to pair the DS-exposed group and the control group with a 1:2 ratio in PPOS ( n = 158 in the DS group and n = 316 in the control group) and GnRH antagonist ( n = 298 in the DS group and n = 596 in the control group) protocols. Five variables were included in the propensity score estimation: age, antral follicle count, basal luteinizing hormone (LH), serum LH, and number of follicles > 10 mm on trigger day. After matching, the DS group demonstrated a significantly prolonged hCG-to-oocyte retrieval interval in both PPOS and GnRH antagonist cohorts. No significant differences were observed in baseline characteristics and hormone levels (all p > 0.05). DS exposure significantly improved oocyte retrieval rate (88.95 ± 17.36 vs. 77.99 ± 22.60, p < 0.001 in PPOS; 89.35 ± 16.70% vs. 78.99 ± 21.21% in GnRH antagonist, p < 0.001) and good-quality embryo rate (62.74 ± 29.06% vs. 49.67 ± 31.54% in PPOS, p < 0.001; 70.6 ± 27.0% vs. 48.0 ± 32.5% in GnRH antagonist, p < 0.001). In the GnRH antagonist cohort, the implantation rate was significantly higher (28.63% vs. 21.38%, p = 0.015) in the DS group in fresh embryo transfer cycles. No significant differences in clinical pregnancy rate and miscarriage rate were observed between the DS-exposed and control groups (all p > 0.05). A single 75-mg diclofenac sodium (DS) tablet administered 20 h after human chorionic gonadotropin (hCG) trigger prolonged the trigger-to-retrieval interval to 39–43 h, significantly increasing good-quality embryo rate and retrieval efficiency without compromising pregnancy outcomes.

Journal of Ovarian Research
Shanghai Jiao Tong University (CN), Shanghai Ninth People's Hospital (CN), Shanghai University of Traditional Chinese Medicine (CN)
Good health and well-being
Reproductive Biology and Fertility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon